查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區細胞化驗分析市場：分析與預測（2023-2032）
市場調查報告書
商品編碼
1424902

亞太地區細胞化驗分析市場：分析與預測（2023-2032）

Asia-Pacific Cell-Based Assay Market: Analysis and Forecast, 2023-2032
出版日期: | 出版商: BIS Research | 英文 63 Pages | 商品交期: 1-5個工作天內

價格

預計到 2032 年，亞太地區細胞化驗分析市場規模將達到 91.9 億美元。

主要市場統計數據
預測期 2023-2032
2023年評估價值 40.5億美元
2032年預測 91.9億美元
複合年成長率 9.53%

2023年亞太細胞化驗分析市場估值為40.5億美元，預計到2032年將達到91.9億美元，2023-2032年預測期間複合年成長率為9.53，預計將為%。由於製藥業不斷增加的藥物研發活動以及這些檢測相對於傳統方法所提供的優越優勢，細胞化驗分析市場正在經歷快速成長。重建人體生理學、預測藥物功效和安全性以及客製化治療方法的能力正在推動市場需求。這一成長也受到慢性病患病率上升和政府支持措施的推動，預計將顯著擴大市場。

由於該地區藥品研發活動的活性化，亞太地區細胞化驗分析市場正在顯著成長。與傳統方法相比，細胞化驗分析具有顯著優勢，有助於其在各個行業中的採用。亞太地區龐大的人口基數、慢性病盛行率的上升以及政府的支持性政策正在進一步推動市場擴張。此外，醫療保健基礎設施的進步以及生物技術和製藥行業投資的增加也推動了市場勢頭。亞太地區專注於個人化醫療和早期藥效預測，已成為全球細胞化驗分析市場的關鍵區域，並有望持續成長和創新。

本報告考察了亞太地區細胞化驗分析市場，概述了市場、國家/地區趨勢以及參與該市場的公司概況。

目錄

執行摘要

第1章 研究範圍

第2章調查方法

第3章市場概況

  • 市場介紹
    • 細胞化驗分析類型
    • 對細胞化驗分析公司的影響

第4章業界考察

  • 概述
  • 美國法律要求與框架
  • 歐洲法律要求和框架
  • 亞太地區的法律要求與框架
    • 日本法律要求與框架

第5章市場動態

  • 概述
  • 影響分析
    • 市場促進因素
    • 市場抑制因素
    • 市場機會

第6章細胞化驗分析市場（按地區），十億美元，2022-2032

  • 概述
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他地區
Product Code: BHL1863SS

The Asia-Pacific Cell-Based Assay Market Expected to Reach $9.19 Billion by 2032

Introduction to Asia-Pacific Cell-Based Assay Market

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$4.05 Billion
2032 Forecast$9.19 Billion
CAGR9.53%

The Asia-Pacific cell-based assay market was valued at $4.05 billion in 2023 and is anticipated to reach $9.19 billion by 2032, witnessing a CAGR of 9.53% during the forecast period 2023-2032. The Cell-Based Assay Market is experiencing rapid growth, propelled by increased drug discovery activities in the pharmaceutical industry and the superior benefits these assays offer compared to conventional methods. Their capability to replicate human physiology, forecast drug effectiveness and safety, and tailor treatments drives market demand. This growth is also fueled by the growing incidence of chronic diseases and government support initiatives, creating a market set for substantial expansion.

Market Introduction

The Asia-Pacific (APAC) Cell-Based Assay Market is witnessing substantial growth due to heightened pharmaceutical research and development activities in the region. Cell-based assays offer significant advantages over traditional methods, driving their adoption across various industries. APAC's large population base, increasing incidence of chronic diseases, and supportive government policies are further propelling market expansion. Additionally, advancements in healthcare infrastructure and rising investments in biotechnology and pharmaceutical sectors contribute to the market's momentum. With a focus on personalized medicine and early drug efficacy prediction, the APAC region is emerging as a key player in the global cell-based assay market, poised for continued growth and innovation.

Market Segmentation

Segmentation 1: by Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC cell-based assay market is anticipated to witness growth during the forecast year 2023-2032. The advent of CRISPR/Cas9 technology has completely transformed gene studies and their functions by offering highly precise and user-friendly genome editing capabilities. CRISPR significantly streamlines the development of more intricate disease-related cell-based assays, enabling researchers to tackle complex questions and study heterogeneous diseases with more relevant and sophisticated assays.

Competitive Strategy: Key players in the APAC cell-based assay market have been analyzed and profiled in the study, including manufacturers involved in new product development, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the APAC cell-based assay market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Research Scope

  • 1.1 Key Questions Answered in the Report:

2 Research Methodology

  • 2.1 Cell-Based Assay Market: Research Methodology
  • 2.2 Primary Data Sources
  • 2.3 Secondary Data Sources
  • 2.4 Market Estimation Model
  • 2.5 Criteria for Company Profiling

3 Markets Overview

  • 3.1 Market Introduction
    • 3.1.1 Types of Cell-Based Assays
  • 3.2 Current and Future State of Cell-Based Assays in Industries
  • 3.3 Emerging Technologies and Applications in the Cell-Based Assay Market
  • 3.4 Current Market Size and Growth Potential, $Billion, 2022-2032
  • 3.5 COVID-19 Impact on Cell-Based Assay Market
    • 3.5.1 Impact on Cell-Based Assay Companies

4 Industry Insights

  • 4.1 Overview
  • 4.2 Legal Requirements and Frameworks in the U.S.
  • 4.3 Legal Requirements and Frameworks in Europe
  • 4.4 Legal Requirements and Frameworks in Asia-Pacific
    • 4.4.1 Legal Requirements and Frameworks in Japan

5 Market Dynamics

  • 5.1 Overview
  • 5.2 Impact Analysis
    • 5.2.1 Market Drivers
      • 5.2.1.1 Increase in Demand for Cell-Based Assay in Drug Discovery and Development
      • 5.2.1.2 Rise in Life Sciences Research Investments
      • 5.2.1.3 Technological Advancements
    • 5.2.2 Market Restraints
      • 5.2.2.1 High Cost
      • 5.2.2.2 Lack of Standardization
    • 5.2.3 Market Opportunities
      • 5.2.3.1 Increased Focus on Regenerative Medicine
      • 5.2.3.2 Emergence of Novel Gene Editing Technologies

6 Cell-Based Assay Market (by Region), $Billion, 2022-2032

  • 6.1 Overview
  • 6.2 Asia-Pacific
    • 6.2.1 China
    • 6.2.2 Japan
    • 6.2.3 India
    • 6.2.4 South Korea
    • 6.2.5 Australia
    • 6.2.6 Rest-of-Asia-Pacific

List of Figures

  • Figure 1: Impact Analysis of Drivers, Challenges, and Opportunities on the Cell-Based Assay Market
  • Figure 2: Cell-Based Assay Market (by Region), 2022
  • Figure 3: Cell-based Assay Market Methodology
  • Figure 4: Primary Research Methodology
  • Figure 5: Top-Down Approach (Segment-Wise Analysis)
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Cellular Processes Utilized to Investigate the Impacts in Cell-Based Assays
  • Figure 8: Emerging Technologies in the Cell-Based Assay Market
  • Figure 9: Asia-Pacific Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 10: Impact of COVID-19 on Cell-Based Assay Companies
  • Figure 11: Cell-Based Assay Market - Market Dynamics
  • Figure 12: Total U.S. Life Sciences Venture Capital Funding, $Billion, 2016-2021
  • Figure 13: Uses of Cell-based Assays in Regenerative Medicine
  • Figure 14: Cell-Based Assay Market Snapshot (by Region)
  • Figure 15: Cell-Based Assay Market (by Region), $Billion, 2022-2032
  • Figure 16: Asia-Pacific Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 17: Asia-Pacific: Market Dynamics
  • Figure 18: Asia-Pacific Cell-Based Assay Market (by Country), $Billion, 2022-2032
  • Figure 19: China Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 20: Japan Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 21: India Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 22: South Korea Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 23: Australia Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 24: Rest-of-Asia-Pacific Cell-Based Assay Market, $Billion, 2022-2032
  • Figure 25: Total Number of Companies Profiled

List of Tables

  • Table 1: Current and Future State of Cell-Based Assay in Industries
  • Table 2: Utilizing the Potential of Cell-Based Assays: Novel Instruments and Methodologies in 2020-2021